DUBLIN--(BUSINESS WIRE)--The "Next generation Sequencing Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.
Next generation sequencing market is projected to expand at a CAGR of 20.21%, to grow from US$4.374 billion in 2017 to US$13.198 billion by 2023.
The global demand for next-generation sequencing (NGS) products and services is highly driven by an increase in the application of NGS, technological advancement in NGS technology, increase in genome mapping programs, and surge in collaborations and partnerships resulting in high investments in R&D in NGS technology.
The efficient replacement of traditional technologies (microarrays), cost efficiency, speed and accuracy of technology along with the rise in the application in drug discovery will aid to the global next-generation sequencing demand growth over next five years.
However, lack of skilled professionals, interpretation of complex data, and legal and ethical issues are expected to hinder the NGS market growth.
Major industry players profiled as part of the report are Roche Holding AG, Agilent Technologies, Thermo Fisher Scientific, Beijing Genomics Institute, GATC Biotech AG, and Pacific Biosciences of California, Inc. among others.
Key Topics Covered
2. Research Methodology
3. Executive Summary
4. Market Dynamics
5. Next Generation Sequencing Market by Products & Services
6. Next Generation Sequencing Market by Technology
7. Next Generation Sequencing Market by Application
8. Next Generation Sequencing Market by Geography
9. Competitive Intelligence
10. Company Profiles
- Roche Holding AG
- Agilent Technologies
- Illumina Inc.
- Thermo Fisher Scientific
- Macrogen Inc.
- Beijing Genomics Institute
- GATC Biotech AG
- Pacific Biosciences of California Inc.
For more information about this report visit https://www.researchandmarkets.com/research/3p65fc/global_next?w=4